Panacea Life Sciences Holdings, Inc.
PLSH· OTC
Filed Aug 22, 2016 · 10-Q · 53 days after period end · 0001415889-16-006940
| Metric | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $213.00 |
| Net Income | -$260.87K | -$112.63K | -$7.67K |
| EPS Diluted | -$0.03 | -$0.22 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 22, 2016 · 53 d after period end